{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05644561",
            "orgStudyIdInfo": {
                "id": "ALXN1210-MG-319"
            },
            "organization": {
                "fullName": "Alexion Pharmaceuticals, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)",
            "officialTitle": "A Phase 3, Open-label, Single-arm, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants (6 to < 18 Years of Age) With Generalized Myasthenia Gravis (gMG)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "evaluation-of-pharmacokinetics-pharmacodynamics-efficacy-safety-and-immunogenicity-of-ravulizumab-administered-intravenously-in-pediatric-participants-with-generalized-myasthenia-gravis-gmg"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-06-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-07-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-07-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-12-01",
            "studyFirstSubmitQcDate": "2022-12-01",
            "studyFirstPostDateStruct": {
                "date": "2022-12-09",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Alexion Pharmaceuticals, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The primary purpose of this study is to characterize the pharmacokinetics and pharmacodynamics of treatment with ravulizumab intravenous infusion in pediatric participants with gMG."
        },
        "conditionsModule": {
            "conditions": [
                "Generalized Myasthenia Gravis",
                "gMG"
            ],
            "keywords": [
                "Generalized Myasthenia Gravis",
                "gMG"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 12,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Ravulizumab Intravenous (IV) Infusion",
                    "type": "EXPERIMENTAL",
                    "description": "All participants will receive a weight-based loading dose of ravulizumab IV on Day 1, followed by weight-based maintenance dose of ravulizumab on Day 15 and once every 8 weeks (q8w) thereafter for participants weighing \u2265 20 kg, or once every 4 weeks (q4w) for participants weighing \\< 20 kg, for a total of 122 weeks of treatment.",
                    "interventionNames": [
                        "Drug: Ravulizumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ravulizumab",
                    "description": "Ravulizumab will be administered by intravenous (IV) infusion.",
                    "armGroupLabels": [
                        "Ravulizumab Intravenous (IV) Infusion"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Plasma Concentration of Ravulizumab",
                    "timeFrame": "Day 1 predose through Week 18 predose"
                },
                {
                    "measure": "Serum Free C5 Concentration of Ravulizumab",
                    "timeFrame": "Day 1 predose through Week 18 predose"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change From Baseline in The Quantitative Myasthenia Gravis (QMG) Total Score at Up to Week 18",
                    "timeFrame": "Baseline, Up to Week 18"
                },
                {
                    "measure": "Change From Baseline in Myasthenia Gravis-Activities Of Daily Living (MG-ADL) Total Score at Up to Week 18",
                    "timeFrame": "Baseline, Up to Week 18"
                },
                {
                    "measure": "Change From Baseline in Myasthenia Gravis Composite (MGC) Score at Up to Week 18",
                    "timeFrame": "Baseline, Up to Week 18"
                },
                {
                    "measure": "Change in Status from Week 10 in Myasthenia Gravis Foundation of America Postintervention Status (MGFA-PIS) as Assessed by the Investigator or Neurologist at Up to Week 18",
                    "timeFrame": "Week 10, Up to Week 18"
                },
                {
                    "measure": "Change from Baseline in Neurology Quality of Life (Neuro QoL) Pediatric Fatigue Score at Up to Week 18",
                    "description": "Participants \u22658 years of age will be evaluated.",
                    "timeFrame": "Baseline, Up to Week 18"
                },
                {
                    "measure": "Change from Baseline in Patient-reported Outcomes Measurement Information System (PROMIS) Parent Proxy - Fatigue Score at Up to Week 18",
                    "description": "Participants \\<8 years of age will be evaluated.",
                    "timeFrame": "Baseline, Up to Week 18"
                },
                {
                    "measure": "Number of Participants With \u22655-point Reduction Compared to Baseline in the QMG Total Score Over Time Through Week 18",
                    "timeFrame": "Baseline through Week 18"
                },
                {
                    "measure": "Number of Participants With \u22653 point Reduction Compared to Baseline in the MG-ADL Total Score Over Time Through Week 18",
                    "timeFrame": "Baseline through Week 18"
                },
                {
                    "measure": "Number of Participants That Improve or Remain Stable in QMG Total Score at Week 18 Compared to Baseline",
                    "description": "Stable is defined as a \u00b15-point change from Baseline.",
                    "timeFrame": "Baseline through Week 18"
                },
                {
                    "measure": "Number of Participants That Improve or Remain Stable in MG ADL Total Score at Week 18 Compared to Baseline",
                    "description": "Stable is defined as a \u00b13-point change from baseline.",
                    "timeFrame": "Baseline through Week 18"
                },
                {
                    "measure": "Number of Participants With Treatment Emergent Adverse Events and Serious Adverse Events",
                    "timeFrame": "Baseline up to Week 126 (8 weeks after last dose of study drug)"
                },
                {
                    "measure": "Number of Participants With Anti-Drug Antibody (ADA) at Week 18",
                    "timeFrame": "Baseline through Week 18"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of gMG confirmed by a positive serologic test for anti-AChR antibodies (Abs) obtained at Screening and/or during Screening Period\n* Myasthenia Gravis Foundation of America (MGFA) Clinical Classification of Class II to Class IV at Screening\n* Participants receiving treatment must be on a stable dosing regimen of adequate duration prior to Screening and during the Screening Period.\n* Eculizumab-experienced participants must have been enrolled and treated with eculizumab in Study ECU-MG-303 for at least 6 months (180 days) and must have been on a stable dose for \u2265 2 months (60 days) prior to Screening.\n* All participants must be vaccinated against meningococcal infection\n\nExclusion Criteria:\n\nMedical Conditions\n\n* Any untreated thymic malignancy, carcinoma, or thymoma.\n* Participants with a history of treated benign thymoma\n* History of thymectomy, thymomectomy, or any thymic surgery within the 12 months prior to Screening\n* History of N meningitidis infection\n* Known to be human immunodeficiency virus (HIV) positive\n* History of unexplained infections\n* Known or suspected history of drug or alcohol abuse or dependence within 1 year prior to the start of the Screening Period",
            "healthyVolunteers": false,
            "sex": "ALL",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Alexion Pharmaceuticals, Inc. (Sponsor)",
                    "role": "CONTACT",
                    "phone": "1-855-752-2356",
                    "email": "clinicaltrials@alexion.com"
                }
            ],
            "locations": [
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90078",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Chapel Hill",
                    "state": "North Carolina",
                    "zip": "27514",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.9132,
                        "lon": -79.05584
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Akron",
                    "state": "Ohio",
                    "zip": "44308",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.08144,
                        "lon": -81.51901
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Marseille",
                    "zip": "13385",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.29551,
                        "lon": 5.38958
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "PARIS Cedex 12",
                    "zip": "75571",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "zip": "20133",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "zip": "00165",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Torino",
                    "zip": "10126",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.07049,
                        "lon": 7.68682
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Itabashi-ku",
                    "zip": "173-0003",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.74893,
                        "lon": 139.71497
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Leiden",
                    "zip": "2333 ZA",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.15833,
                        "lon": 4.49306
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Belgrade",
                    "zip": "11000",
                    "country": "Serbia",
                    "geoPoint": {
                        "lat": 44.80401,
                        "lon": 20.46513
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Belgrade",
                    "zip": "11070",
                    "country": "Serbia",
                    "geoPoint": {
                        "lat": 44.80401,
                        "lon": 20.46513
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Malaga",
                    "zip": "29010",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 36.72016,
                        "lon": -4.42034
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Bern",
                    "zip": "3010",
                    "country": "Switzerland",
                    "geoPoint": {
                        "lat": 46.94809,
                        "lon": 7.44744
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Alexion has a public commitment to allow requests for access to study data and will be supplying a protocol, CSR, and plain language summaries.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "CSR"
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009157",
                    "term": "Myasthenia Gravis"
                },
                {
                    "id": "D000018908",
                    "term": "Muscle Weakness"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009135",
                    "term": "Muscular Diseases"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                },
                {
                    "id": "D000020879",
                    "term": "Neuromuscular Manifestations"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000020361",
                    "term": "Paraneoplastic Syndromes, Nervous System"
                },
                {
                    "id": "D000009423",
                    "term": "Nervous System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000010257",
                    "term": "Paraneoplastic Syndromes"
                },
                {
                    "id": "D000020274",
                    "term": "Autoimmune Diseases of the Nervous System"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000020511",
                    "term": "Neuromuscular Junction Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12112",
                    "name": "Myasthenia Gravis",
                    "asFound": "Myasthenia Gravis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20944",
                    "name": "Muscle Weakness",
                    "asFound": "Myasthenia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13204",
                    "name": "Paresis",
                    "relevance": "LOW"
                },
                {
                    "id": "M4554",
                    "name": "Asthenia",
                    "relevance": "LOW"
                },
                {
                    "id": "M12092",
                    "name": "Muscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22619",
                    "name": "Neuromuscular Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M13170",
                    "name": "Paraneoplastic Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M22160",
                    "name": "Paraneoplastic Syndromes, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M12367",
                    "name": "Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22094",
                    "name": "Autoimmune Diseases of the Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22297",
                    "name": "Neuromuscular Junction Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3973",
                    "name": "Myasthenia Gravis",
                    "asFound": "Myasthenia Gravis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000629409",
                    "term": "Ravulizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000051056",
                    "term": "Complement Inactivating Agents"
                },
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M287455",
                    "name": "Ravulizumab",
                    "asFound": "CCT",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6392",
                    "name": "Complement System Proteins",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}